Key Takeaways
- Boeing (BA) factory workers in St. Louis have rejected a new five-year contract, extending a three-month strike at the company’s crucial military manufacturing hub. The rejected offer included an average wage boost of 24% over five years, which the union deemed insufficient compared to agreements for other Boeing employees.
- The U.S. and China have reached a framework for a trade deal, with China expected to delay rare earth export controls and resume significant purchases of U.S. soybeans. This development, confirmed by U.S. Treasury Secretary Scott Bessent, aims to avert new 100% tariffs and de-escalate the prolonged trade war.
- Novartis (NVS) is reportedly set to announce the acquisition of Avidity Biosciences (RNA) for over $10 billion. This potential deal highlights continued significant M&A activity in the biotechnology sector.
- Japan's new Prime Minister, Sanae Takaichi, has begun her tenure with a strong 71% approval rating, according to a Yomiuri Shimbun survey. Her election marks a historic moment as Japan's first female prime minister, with the Nikkei index having surged on expectations of her market-friendly policies.
Boeing Strike Continues Amid Contract Rejection
Factory workers at Boeing's (BA) St. Louis facilities have voted to reject a new five-year contract proposal, prolonging a strike that has impacted the company's vital military manufacturing operations for three months. The offer included an average wage increase of 24% over the contract's duration.
The International Association of Machinists and Aerospace Workers (IAM) District 837, representing over 3,200 striking employees, stated that the offer "fell short of addressing the priorities and sacrifices" of its members. Workers are reportedly seeking a deal comparable to one accepted by Seattle-area Boeing employees in November of last year, which included a 38% general wage increase over four years, higher retirement contributions, and a signing bonus. Boeing has expressed disappointment with the rejection, maintaining that its offer was "strong" and included a 40% average wage growth, and has indicated no further talks are currently scheduled. The strike affects the production of critical military aircraft, including F-15 and F/A-18 fighters.
US and China Near Trade Deal, Easing Rare Earth and Soybean Tensions
The United States and China have reached a preliminary framework for a trade agreement, signaling a potential de-escalation in their protracted trade dispute. U.S. Treasury Secretary Scott Bessent announced that China is expected to delay its expanded export controls on rare earth minerals and magnets for a year while the policy is re-examined. This agreement also anticipates a resumption of substantial U.S. soybean purchases by China.
Secretary Bessent, who notably stated, "I'm actually a soybean farmer, so I have felt this pain too," highlighted the impact of the trade tensions on American agriculture. The framework was established during talks between top economic officials on the sidelines of the ASEAN Summit in Kuala Lumpur and is expected to be finalized when President Donald Trump meets Chinese President Xi Jinping in South Korea this week. This progress aims to avert new 100% U.S. tariffs on Chinese goods that were threatened to begin on November 1.
Novartis Poised for $10 Billion-Plus Avidity Biosciences Acquisition
Pharmaceutical giant Novartis AG (NVS) is reportedly on the verge of announcing a significant acquisition, with plans to purchase Avidity Biosciences Inc (RNA) for a sum exceeding $10 billion. While both companies have declined to comment on the reports, the news underscores a continued trend of substantial mergers and acquisitions within the biotechnology and pharmaceutical sectors.
Avidity Biosciences is a biopharmaceutical company focused on developing a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs), with a pipeline targeting rare muscle diseases. This strategic move by Novartis would bolster its portfolio in novel therapies and expand its presence in the rapidly evolving biotechnology landscape.
Japan Welcomes New PM Takaichi with High Approval
Sanae Takaichi has taken office as Japan's new Prime Minister, marking a historic moment as the nation's first female leader. Her cabinet has garnered a robust 71% approval rating in a recent Yomiuri Shimbun survey, a significant increase from the previous administration's rating.
Takaichi's ascent to power, following her election as the leader of the ruling Liberal Democratic Party (LDP), has already impacted financial markets. The Nikkei 225 index surged to record highs ahead of her confirmation, driven by investor expectations of her commitment to market-friendly "Abenomics" stimulus policies. Her administration faces challenges including revitalizing Japan's competitiveness, strengthening its industrial base, and addressing an aging population and mounting public debt.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.